Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
Titel:
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
Auteur:
Nickles, Emily Dharmadhikari, Bhushan Yating, Li Walsh, Robert J. Koh, Liang Piu Poon, Michelle Tan, Lip Kun Wang, Ling-Zhi Ang, Yvonne Asokumaran, Yugarajah Chong, Wan Qin Huang, Yiqing Loh, Kwok Seng Tay, Joshua Soo, Ross Koh, Mickey Ho, Liam Pock Chan, Marieta Niam, Madelaine Soh, Melissa Luah, Yen Hoon Lim, Chwee Ming Kaliaperumal, Nivashini Au, Veonice B. Talib, Najwa Binte Said Nasir Sng, Reina Connolly, John E. Goh, Boon Cher Schwarz, Herbert